Dec 21, 2022MitoSense and Uppsala University's Centre for Transplantation Technology Enter into Strategic MOUGREAT FALLS, Va., Dec. 21, 2022 /PRNewswire/ -- Today, Uppsala University's Centre for Transplantation Technology (CTTM) and US-based...
Sep 12, 2022MitoSense and U.S. Dept. of Veterans Affairs Selected to Present Science at Major Medical ConferenceGREAT FALLS, Va., Sept. 12, 2022 /PRNewswire/ -- MitoSense, Inc., a life-science company focused on harnessing the power of mitochondria...
Jun 9, 2022MitoSense Names Former U.S. Ambassador to Switzerland, Ed McMullen, as Senior Advisor to BoardGREAT FALLS, Va., June 9, 2022 /PRNewswire/ -- MitoSense, Inc., a life-science company focused on harnessing the power of mitochondria to...
Apr 27, 2022MitoSense's CRADA and ALS Work Recognized in Congressional Record U.S. Congressman Neal Dunn publicly recognized work related to MitoSense's research and development of treatments for amyotrophic lateral...
Jan 27, 2022MitoSense and the U.S. Department of Veterans Affairs Enter into Agreement (CRADA)MitoSense has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Veterans Affairs (VA).
Feb 11, 2021A Tribute to Dr. Robert Elliott: A Pioneer in Cancer and ALS ResearchGinny Dent Bryant posts a tribute to Dr. Elliott as well as lessons she learned from him regarding cancer. You can find both here.
Feb 5, 2021Newsmax Op-Ed: Medical Pioneer Fought Relentlessly for Patients' LivesVan Hipp recounts the life and works of Dr. Elliott. Read here.